You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

left ventricular thrombus;anterior myocardial infarction

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Laboratory Indices to Left Ventricular Thrombus Formation in

Not yet recruiting
  • Left Ventricular Thrombus
  • Primary percutaneous coronary intervention or thrombolytic therapy
  • (no location specified)
Nov 29, 2023

Myocardial Infarction, Acute, Left Ventricular Thrombus Trial in Paris (Rivaroxaban 2.5 MG [Xarelto], DAPT strategy)

Recruiting
  • Myocardial Infarction, Acute
  • Left Ventricular Thrombus
  • Rivaroxaban 2.5 MG [Xarelto]
  • DAPT strategy
  • Paris, France
    HEGP
Oct 22, 2021

Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI

Completed
  • Left Ventricular Thrombus
  • +2 more
  • inflammatory indexes and CHA2DS2-VASc score
  • (no location specified)
Apr 28, 2021

ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus Trial in Chang chun (Rivaroxaban 15 MG [Xarelto])

Recruiting
  • ST-segment Elevation Myocardial Infarction (STEMI)
  • Left Ventricular Thrombus
  • Rivaroxaban 15 MG [Xarelto]
  • Chang chun, Jilin, China
    Jilin university
May 28, 2023

STEMI - ST Elevation Myocardial Infarction Trial in Zunyi (NOAC+DAPT, DAPT)

Recruiting
  • STEMI - ST Elevation Myocardial Infarction
  • Zunyi, Guizhou, China
    Affiliated Hospital of Zunyi Medical University
Aug 25, 2023

Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)

Not yet recruiting
  • Left Ventricular Thrombus
  • Myocardial Infarction
  • (no location specified)
Mar 31, 2023

Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction Trial in Tehran (Rivaroxaban 15 MG, Warfarin)

Recruiting
  • Left Ventricular Thrombus
  • ST Segment Elevation Myocardial Infarction
  • Tehran, Iran, Islamic Republic of
  • +1 more
Jan 21, 2023

ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])

Not yet recruiting
  • ST Elevation Myocardial Infarction (STEMI)
  • Rosuvastatin 20 mg
  • Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
  • (no location specified)
Feb 1, 2023

STEMI Trial in Cairo (Dapagliflozin)

Recruiting
  • STEMI
  • Cairo, Egypt
    Helwan University
Jul 16, 2023

Left Ventricular Thrombus Trial in Dammam (Apixaban, Warfarin)

Completed
  • Left Ventricular Thrombus
  • Dammam, Saudi Arabia
    Saud AlBabtain Cardiac Center
Jan 12, 2022

Long QT Syndrome, Sinus Bradycardia, Sinus Tachycardia Trial in Taoyuan city (Chang Gung ECG Abnormality Detection Software)

Not yet recruiting
  • Long QT Syndrome
  • +9 more
  • Chang Gung ECG Abnormality Detection Software
  • Taoyuan city, Taiwan
    Chang Gung memorial hospital
Jun 6, 2023

Acute Myocardial Infarction, Left Ventricular Thrombosis, Anticoagulants and Bleeding Disorders Trial in Jerusalem (Apixaban

Completed
  • Acute Myocardial Infarction
  • +2 more
  • Jerusalem, Israel
    Hadassah Medical Organization
Aug 24, 2021

AMI, STEMI, NSTEMI Trial in Paris (Dapagliflozin propanediol (FORXIGA™/FARXIGA™1), Placebo comparator)

Not yet recruiting
  • AMI
  • +3 more
  • Dapagliflozin propanediol (FORXIGA™/FARXIGA™1)
  • Placebo comparator
  • Paris, France
    Department of Cardiology AP-HP Hôpital européen Georges - Pompid
Mar 1, 2023

SuperSaturated Oxygen (SSO2) Therapy Clinical Utility

Not yet recruiting
  • Acute ST Segment Elevation Myocardial Infarction
    • (no location specified)
    Jul 14, 2023

    Left Ventricular Remodeling in Type 2 Diabetic Acute Myocardial

    Recruiting
    • Myocardial Infarction
    • Diabetes Mellitus, Type 2
    • SGLT2 inhibitor
    • Seoul, Korea, Republic of
      Seoul St. Mary's Hospital
    Mar 5, 2023

    Myocardial Infarction Trial in Gainesville (OPL-0301 Dose 1, OPL-0301 Dose 2, Placebo)

    Not yet recruiting
    • Myocardial Infarction
    • OPL-0301 Dose 1
    • +2 more
    • Gainesville, Georgia
      Site 1
    Aug 31, 2022

    ST Elevation Myocardial Infarction, Heart Failure Trial in Shenyang (Levosimendan, )

    Enrolling by invitation
    • ST Elevation Myocardial Infarction
    • Heart Failure
    • Shenyang, Liaoning, China
      Shengjing Hospital
    Aug 19, 2021

    Acute Coronary Syndrome, Left Ventricular Thrombus Trial in Karachi (Rivaroxaban, Warfarin)

    Recruiting
    • Acute Coronary Syndrome
    • Left Ventricular Thrombus
    • Karachi, Sindh, Pakistan
      National Institute of Cardiovascular Diseases
    Jul 10, 2021

    ST Elevation Myocardial Infarction Trial in Caen ((15)-O water positron emission tomography and Biomarkers)

    Suspended
    • ST Elevation Myocardial Infarction
    • (15)-O water positron emission tomography and Biomarkers
    • Caen, Normandie, France
      CHu de Caen
    Mar 8, 2022

    Myocardial Infarction Trial in Oxford (PICSO)

    Recruiting
    • Myocardial Infarction
    • PICSO
    • Oxford, United Kingdom
      Oxford Heart Centre
    Sep 19, 2022

    Chronic Ischemic Left Ventricular Dysfunction Trial (Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells, Human Embryonic

    Recruiting
    • Chronic Ischemic Left Ventricular Dysfunction
    • Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells
    • +2 more
    • Palo Alto, California
      Stanford Hospital and Clinics
    Sep 15, 2022

    Acute Cardiac Dysfunction in Critical Illnes

    Not yet recruiting
    • Multi Organ Failure
    • +5 more
    • Echocardiography
    • +2 more
    • (no location specified)
    May 16, 2023

    Anterior MI, Colchicine Trial in Cairo (Colchicine 0.5 mg Oral Tablet)

    Not yet recruiting
    • Anterior MI
    • Colchicine
    • Colchicine 0.5 mg Oral Tablet
    • Cairo, Egypt
      Ain Shams University hospitals
    Feb 11, 2022

    The "MyoThrombus" Study

    Recruiting
    • Left Ventricular Thrombus
    • +3 more
    • 18F-GP1 PET/MR
    • Edinburgh, United Kingdom
      Royal Infirmary Edinburgh
    Apr 9, 2021

    Anterior Myocardial Infarction, Heart Failure Trial in Rome (rhu G-CSF, optimal standard of care, Myocardial Contrast

    Withdrawn
    • Anterior Myocardial Infarction
    • Heart Failure
    • rhu G-CSF
    • +2 more
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli
    Mar 28, 2022